TrialBlood2011

Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies.

Joseph Rosenthal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.